Received Sep 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | — |
36 hours in bed with flu; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (36 hours in bed with flu) in a female patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA (36 hours in bed with flu). At the time of the report, INFLUENZA (36 hours in bed with flu) had resolved. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Unknown) was unknown. Relevant Medical History (vaccines within the past 4 weeks, medical conditions) were reported as unknown. No concomitant medication was reported. The patient had, since the Moderna vaccine was released, consistently kept up with the updates, starting in 2021. Every other Moderna vaccine she received, she experienced about 36 hours in bed with the flu, a sort of feverish and achy skin which she had expected. The patient had always managed it. In the recent vaccine mNEXSPIKE, the patient did not have the usual flu-like symptoms. It was unknown if the patient experienced any additional symptoms/events. No treatment medication was reported. This case was linked to MOD-2025-789447 (Patient Link).